Teleflex (TFX) Stock: Buy, Sell, or Hold?
TFX - Teleflex Incorporated
$129.91
-2.09 (-1.59%)
▼
5d:
-7.18%
30d:
-4.71%
90d:
+0.46%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TFX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TFX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$228.20
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$141.70
8.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TFX is currently trading at $129.91, which is considered oversold relative to its 30-day fair value range of $133.99 to $140.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.7). At these levels, the market is pricing in 4.1% annual earnings growth.
Technical Outlook: Technically, TFX is showing support break momentum. The price is currently testing key support at $128.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $153.55 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TFX is showing support break momentum. The price is currently testing key support at $128.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $153.55 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$133.99 -
$140.05
Company Quality Score
48/100
(HOLD)
Options IV Signal
24th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
84.2%
Protect Your Profits
Holding TFX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($153.55)
- BULLISH: Expecting earnings turnaround to 4.1% growth with 28.9% revenue growth
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$133.99 -
$140.05
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$6.85
(5.3%)
Support & Resistance Levels
Support Level
$128.98
Resistance Level
$144.16
Current Trend
Support Break
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.05
Wall Street Target
$153.55
(+16.3%)
Revenue Growth (YoY)
28.9%
Earnings Growth (YoY)
-17.3%
Profit Margin
-45.8%
Valuation Premium vs History
+4.1% premium
PE vs Historical
12.1 vs 10.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$137.41
(+4%)
2-Year Target
$143.05
(+8%)
3-Year Target
$148.91
(+13%)
3-Yr Target (if PE normalizes)
(PE: 12→11)
PE COMPRESSION
$132.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 54.8%)
$745.54
(+465%)
Base:
(SPY PE: 12.1, Growth: 54.8%)
$445.50
(+238%)
Bear:
(PE: 10.2, Growth: 54.8%)
$378.68
(+187%)
Share & Embed Analysis
Last updated: September 11, 2026 1:40 PM ET
Data refreshes hourly during market hours. Next update: 2:40 PM
Data refreshes hourly during market hours. Next update: 2:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced TFX Option Strategies
Professional options setups generated by AI based on today's TFX price and gamma walls.
